• NICE recommends prasugrel (Efient) for preventing blood clots in people with acute coronary syndromes

    Healthcare guidance body NICE has reviewed its guidance on prasugrel (Efient, Eli Lilly and Company). The updated guidance published today recommends the drug in combination with aspirin for preventing blood clots in people who have had a heart attack or who have unstable angina (collectively called acute coronary syndromes) and who are also having a procedure to widen narrowed arteries in the heart (percutaneous coronary interventioni).

    23 July 2014

Press releases for last 7 days

Get involved